According to a report by MarketsandMarkets, the global freeze-drying/lyophilization equipment market is expected to reach $7.3 billion by 2025—from $4.9 billion in 2020—at a CAGR of 8.2%.
In this article, we discuss the factors that are driving the demand of lyophilized products and why many pharma and biotech companies are turning to partners such as Emergent, to support the drug process/formulation development and manufacturing of lyophilized biological products.
